Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.

Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Published

Blinding and expectancy confounds in psychedelic randomized controlled trials.

An abstract is available from the original source but is not redistributed by this database. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal
Expert review of clinical pharmacology
Date
2021-09-01
Source
PubMed
DOI
10.1080/17512433.2021.1933434
PubMed
34038314
Record provenance and attribution

The listed authors receive credit for the original research. This tracker aggregates source metadata and derives discovery labels; inclusion is not scientific validation.

Source identifier
Indexed
2026-07-01 06:48:06 UTC
Metadata last checked
2026-08-09 08:28:22 UTC

Checking metadata does not mean individual manual review. Cite the original work for its findings and the exact dataset snapshot and software version for analyses.

Machine-readable provenance

Authors

Watch author

Derived topics and classifications

These labels are search aids derived from indexed metadata, not an assessment of evidence quality. Verify the study design and findings in the original source.

Citation graph

0 referenced DOIs found in stored source metadata. 20 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Psychedelic assisted psychotherapy (2020-2025): a scoping review of clinical evidence, mechanisms, safety, and ethics2026-10-27Participant experiences and recommendations for psychedelic clinical trials and future treatment delivery: a qualitative study with experts by experience from the Psychedelic Participant Advocacy Network2026-10-14Caution before canonisation: a clinical and implementation science perspective on psychedelics2026-10-05Longitudinal neural and psychological changes following psilocybin under compassion imagery priming2026-07-22Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overview2026-07-13Psilocybin therapy for adult females with anorexia nervosa: pilot study2026-07-08Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depression2026-06-01Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major Depression2026-05-15Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of Care2026-05-14Psilocybin in the Treatment of Cocaine Use Disorder2026-05-07Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression2026-05-01Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysis2026-04-01Psilocybin-induced alterations in EEG power, connectivity and network dynamics in healthy subjects: Correlations with subjective experience and implications for therapeutic applications2026-03-01Psilocybin Use in an Intercollegiate Athlete with Persisting Symptoms After Concussion: A Case Report2025-07-01Psilocybin-gestützte Therapie von Depression, Angst und Suchtstörungen: Neurobiologische Grundlagen und klinische Anwendung2025-05-01Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for Depression2024-04-15Classic Psychedelics for the Treatment of Depressive Disorders: An Update for Psychiatrists in Training2023-09-08Psilocybin to promote synaptogenesis in the brains of patients with mild cognitive impairment2023-04-05The therapeutic potential of psychedelics: the European regulatory perspective2023-02-10Dark Side of the Shroom: Erasing Indigenous and Counterculture Wisdoms with Psychedelic Capitalism, and the Open Source Alternative2022-08-22

Related papers